Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenblum, W. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenblum, W. I.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Stroke, Vol 16, 262-263, Copyright © 1985 by American Heart Association


ARTICLES

Constricting effect of leukotrienes on cerebral arterioles of mice

WI Rosenblum

Three leukotrienes (LTB4, C4, D4) were locally applied to cerebral arterioles in doses varying from 3 X 10(-8) to 4 X 10(-7) M and each produced a dose related constriction. LTC was tested in the presence and absence of FPL-55712, a relatively specific inhibitor of leukotriene receptors. A low dose (10(-8) M) of FPL-55712 did markedly reduce the response to the LTC and did not significantly alter an equally pronounced constriction produced by norepinephrine. The constricting properties of the leukotrienes shown by our data support the suggestion that these products of lipoxygenase's action on arachidonic acid have the potential to modify cerebrovascular tone. This potential may be important in view of recent evidence showing that the brain can make significant amounts of leukotrienes from arachidonic acid.